A New Era in Bladder Cancer Treatment: Targeted Therapy Offers Hope – Daniel Chong, MD, Virginia Cancer Specialists

Bladder cancer, though not as widely discussed as some other cancers, is a significant health concern worldwide. With approximately 82,000 new cases each year, and sadly, 16,700 annual deaths attributed to it, it demands attention and innovative solutions. Fortunately, advancements in medical science have led to a greater understanding of bladder cancer and improved […]
Bladder Cancer Awareness, Risks, Symptoms, and Treatment Options – Daniel Chong, MD

More than 83,000 people in the U.S. will be diagnosed with bladder cancer this year, according to the American Cancer Society. While rates of bladder cancer are four times higher in men than in women, bladder cancer affects men and women of all ages and races. However, in recent years, the rates of bladder cancer […]
Head and Neck Cancer: Symptoms and Treatment Options

While often referred to as head and neck cancer, the term itself isn’t a diagnosis. Instead, head and neck cancer indicates the area of the body where the cancer originated, most commonly in the mouth, throat, sinuses, or salivary glands, but does not include cancer of the brain or eyes. The good news is […]
Dr. Mitul Gandhi, Medical Oncologist at Virginia Cancer Specialists, Co-Authors Real-World Study Assessing Efficacy of Azacitidine in Treatment-Naive Patients with Higher-Risk Myelodysplastic Syndromes

Dr. Mitul Gandhi, Medical Oncologist at Virginia Cancer Specialists, Co-Authors Real-World Study Assessing Efficacy of Azacitidine in Treatment-Naive Patients with Higher-Risk Myelodysplastic Syndromes This study highlights the need for new therapies that improve complete remission and survival rates in patients with HR-MDS. Fairfax, Virginia, February 9, 2024 – Virginia Cancer Specialists, a premier provider of […]
Podcast Today! How new technology and insights are impacting breast cancer treatment – David Weintritt, MD, FACS

Live Podcast today! https://www.linkedin.com/…/hownewtechnologyand…/theater/
Advancements in Colorectal Cancer Treatment: Insights from Samuel Lee, MD at Virginia Cancer Specialists

The treatment paradigm for colorectal cancer is continuously evolving towards more personalized treatment plans. With more research conducted over the past decade, we are transitioning away from a one-size-fits-all approach to more individualized treatments for all stages of colorectal cancer. Early and Locally Advanced Colon Cancer: Upfront surgery remains the mainstay of treatment. Treatment after […]
Redefining Cancer Treatment With Personalized Medicine and Early Intervention – Geoffrey Moorer, MD

Trends in the treatment for patients with cancer are shifting towards earlier intervention, with effective therapies like immunotherapy moving into neoadjuvant stages for improved outcomes. However, Geoffrey D. Moorer, MD, believes that challenges remain in ensuring wider access to sequencing and overcoming data complexity. While the future holds immense potential for artificial intelligence to revolutionize […]
Understanding the Role of Palliative Care in Cancer Treatment – Muhammad Siddiqui, MD

Role of Palliative Care in Cancer Treatment In an interview with Targeted Oncology, Muhammad Siddiqui, MD, explained the role that palliative medicine plays in a cancer treatment plan and how oncologists and palliative care physicians can work together in patients’ best interests. Palliative care physicians work to improve the quality-of-life of patients with serious or […]
Abemaciclib in the Treatment of Early-Stage Hormone Receptor-Positive Breast Cancer – Anmol Singh, MD

Endocrine therapy remains a mainstay in the treatment of early-stage hormone receptor-positive breast cancer. However, oncologists continue to work on improving the risk of recurrence in patients whose tumors exhibit high-risk features, such as a larger size or lymph node involvement. The MonarchE trial, a randomized phase 3 trial in adults, examined how the addition […]
Brentuximab Vedotin: A Promising Frontline Therapy for Older Hodgkin Lymphoma Patients

A recent study published by Dr. Dipti Patel-Donnelly, of Virginia Cancer Specialists and colleagues has shed light on a groundbreaking approach in the treatment of advanced-stage classical Hodgkin lymphoma (cHL) in older patients. This noncomparative phase 2 study, detailed in the research article here, explores the efficacy of brentuximab vedotin (BV) in combination with dacarbazine […]